CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

MethodSense has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Life Science Compliance Solution Companies - 2021,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with , .

MethodSense
Regulatory Compliance Through Software And Services

MethodSense

Rita King, CEO and Senior Regulatory Consultant, MethodSenseRita King, CEO and Senior Regulatory Consultant
Technological advancements in the fields of pharmaceuticals, biotechnology, and medical devices bring new compliance challenges with them. Modern and granular regulatory scrutiny for product submissions increase the time to market of products and tend to increase the cost of production. As a premier consultant in the medical sciences, MethodSense, based in Research Triangle Park, NC, helps clients tackle these compliance-related challenges. The company offers InfoStrength—a regulatory compliance information management software—to augment its consulting services and to ensure requirements are met during projects and product development cycles.

InfoStrength software was the result of the years of experience and knowledge of its founders regarding the needs of the life science industry. The software is tailored to cater and support life-science businesses in the areas of product design, development, commercialization, and operations management among others. The solution allows companies to manage critical business operations and control content from one place. Rita King, CEO and Senior Regulatory Consultant, explains, “Our platform enables our clients to safely and securely share information and collaborate with their suppliers and partners while retaining control of their IP and addressing multiple international regulations.”

MethodSense's consultants adapt to varied client needs and deliver services that effectively meet global regulatory requirements. Consultants formulate astute commercialization strategies that ensure quality compliance and deal with product submissions, usability studies, quality management system development and management, software validation, risk file management, and other services.

All along, they ensure regulatory compliance for the clients operating in the global markets. Also, MethodSense conducts internal compliance audits, provides leadership to support strategic direction and acts as a virtual quality department for the clients seeking clearance of their products.

In the life sciences industry, information management is not only about the preservation of data, but also about IP protection. InfoStrength enables its clients to meet regulatory requirements of ISO 9000, FDA 21 CFR Part 11, Part 820 Quality System Regulation, ISO 13485and Annex 11effectively. The company maintains data integrity throughout the development, implementation, and maintenance of design controls. Though these restrictions are mandatory and stipulated by the industry regulations, MethodSense customizes them for the specific needs of the business through a variety of product offerings. As a software product developer and regulatory consultants, MethodSense is well versed in enforcing software development lifecycle requirements and methodologies, and in implementing software risk management and validation, which have become instrumental for clients who integrate software into their products.
  • MethodSense conducts internal compliance audits, provides leadership to support strategic direction and acts as a virtual quality department for the clients seeking clearance of their products.


Abiding by its guiding principles of always seeking opportunities to learn and the core belief that a team is stronger than an individual, MethodSense employs a vibrant team that works tirelessly to help their clients become acquainted with FDA and other regulatory norms in the life-sciences industry. The team has successfully supported organizations with sophisticated medical devices with their combination of software and services. For an international medical device company, MethodSense helped identify and develop a product that, through its commercialization, strengthened a partnership with a large pharmaceutical company and created early market entry opportunities for the client and their partner. MethodSense identified the necessary deliverables that were required to bring the product to the market and managed the strategy to attain product realization. The company completed the combination project from initiation to FDA clearance within 12 months, enabling the client to generate profits within the first year of product commercialization.

Recently, MethodSense guided a team of engineers through the commercialization process of a medical device. Taking care of the development of a quality management system, product lifecycle, risk management, and human factors validation, the company helped the clients to bring the product to the market in 18 months. In the near future, MethodSense aspires to be a recognized leader in the life science space while executing growth plans with an unwavering focus on client success.

Top 10 Life Science Compliance Solution Companies - 2021
Current Issue

Company : MethodSense

Management
Rita King, CEO and Senior Regulatory Consultant

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/methodsense